Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
SLN · against 458 other Healthcare companies of similar size
Ranked #133 of 459 · scores higher than 71% of peers · safety percentile 74
Bars: peers in each 10-point band of the safety percentile (higher = safer; 67+ earns the lower-risk grade)52 peers with a safety percentile of 70–79, including SLN · Click a bar to see the companies
Mainly thanks to its debt / equity and current ratio, which are stronger than most Healthcare peers.
Risk is relative to the sector, not a bankruptcy probability. Banks and brokers carry high leverage by design, and share buybacks can shrink equity and current assets, which raises debt/equity on paper.
| Metric | SLN | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Debt / equityLower is better · 433 reported | 0.00× | 0.20× | 96% | 33% | |
| BetaLower is better · 432 reported | 1.45 | 0.49 | 11% | 33% | |
| Current ratioHigher is better · 445 reported | 7.42× | 2.91× | 81% | 33% |
| Rank | Company | Market cap | Safety | Overall |
|---|---|---|---|---|
| 1 | 1.5B USD | 100 | 44 | |
| 2 | 1.2B USD | 100 | 40 | |
| 3 | 1.1B USD | 100 | ||
| 4 | 1.0B USD | 99 | 35 | |
| 5 | 1.2B USD | 99 | ||
| 129 | 6.0B CNY (≈$841M) | 75 | 50 | |
| 130 | 254.3B JPY (≈$1.7B) | 74 | 61 | |
| 131 | 879M USD | 74 | 36 | |
| 132 | 7.2B CNY (≈$1.0B) | 74 | 61 | |
| 133 | 1.2B USD | 74 | 21 | |
| 134 | 263.1B JPY (≈$1.8B) | 74 | 72 | |
| 135 | 9.0B CNY (≈$1.3B) | 73 | 45 | |
| 136 | 13.3B CNY (≈$1.9B) | 73 | 49 | |
| 137 | 2.3B USD | 73 | 27 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score